https://www.selleckchem.com/products/blu-554.html
The primary outcome measure will be the percent change in the RMTs of the thenar muscles at baseline and after the intervention. The secondary outcome measures will be the amplitude (μV) and latency (ms) of the MEPs of the thenar muscles at baseline and after the intervention. The aim of this trial is to explore the effect of opposing needling on the excitability of M1 of healthy participants and patients with post-stroke hemiplegia. Chinese Clinical Trial Registry ChiCTR1900028138 . Registered on 13 December 2019. Chinese Clinical Tria
Like
Comment
Share
